Growing community of inventors

Poway, CA, United States of America

Michael E Deason

Average Co-Inventor Count = 3.16

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 31

Michael E DeasonKathleen R Whitten (5 patents)Michael E DeasonWilliam D Dean (4 patents)Michael E DeasonRaymond E Conrow (3 patents)Michael E DeasonSteven Lee Bender (3 patents)Michael E DeasonPaul W Zinke (3 patents)Michael E DeasonMichael J Melnick (3 patents)Michael E DeasonAnura P Dantanarayana (3 patents)Michael E DeasonScott E Zook (3 patents)Michael E DeasonRaymond Dagnino, Jr (3 patents)Michael E DeasonSteven J Sproull (3 patents)Michael E DeasonTakashi Inaba (2 patents)Michael E DeasonYasuki Yamada (2 patents)Michael E DeasonJames Shanley (2 patents)Michael E DeasonDavid R Pierce (1 patent)Michael E DeasonMichael E Deason (14 patents)Kathleen R WhittenKathleen R Whitten (12 patents)William D DeanWilliam D Dean (12 patents)Raymond E ConrowRaymond E Conrow (29 patents)Steven Lee BenderSteven Lee Bender (26 patents)Paul W ZinkePaul W Zinke (21 patents)Michael J MelnickMichael J Melnick (13 patents)Anura P DantanarayanaAnura P Dantanarayana (13 patents)Scott E ZookScott E Zook (12 patents)Raymond Dagnino, JrRaymond Dagnino, Jr (7 patents)Steven J SproullSteven J Sproull (3 patents)Takashi InabaTakashi Inaba (36 patents)Yasuki YamadaYasuki Yamada (12 patents)James ShanleyJames Shanley (2 patents)David R PierceDavid R Pierce (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Agouron Pharmaceuticals, Inc. (8 from 174 patents)

2. Other (3 from 832,680 patents)

3. Japan Tobacco Inc. (3 from 1,037 patents)

4. Alcon Laboratories, Inc. (3 from 449 patents)


14 patents:

1. 6849732 - Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation

2. 6605721 - Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors

3. 6512135 - Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors

4. 6500948 - Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof

5. 6407285 - Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors

6. 6303786 - Processes for making nelfinavir mesylate

7. 6153757 - Metalloproteinase inhibitors and intermediates useful for their

8. 612146 - Process for producing amide derivatives and intermediate compounds

9. 6121468 - Process for producing amide derivatives and intermediate compounds

10. 5962725 - Intermediate compounds useful for making HIV protease inhibitors such as

11. 5684156 - Process for preparation of clonidine derivatives

12. 5473067 - Preparation of carbonic anhydrase inhibitors

13. 5424448 - Preparation of carbonic anhydrase inhibitors

14. 5344929 - Preparation of carbonic anhydrase inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…